MedAdvisor extends deal with GSK by 12 months

Company News

by David Chau

MedAdvisor Limited’s (ASX:MDR) service agreement with global pharmaceuticals giant, GlaxoSmithKline Australia Pty Ltd, has been extended by another 12 months.

MedAdvisor is an electronic medication management software. It connects patients to their local pharmacy and provides them with real time access to their personal medication records.

Under the agreement, GSK will continue to provide tailored messages to patients that have been prescribed medications within its respiratory portfolio.

MedAdvisor says it will receive Patient Engagement Program revenue from GSK for the use of its software.

MedAdvisor reported a net loss of $1.1 million at 31 December 2015.

David Chau

Finance News Network
David joined FNN in April 2016. In addition to presenting the Market Outlook and latest business news stories, David interviews senior economists and CEOs of ASX-listed companies. Prior to working for FNN, David was a litigation lawyer.